首页 | 本学科首页   官方微博 | 高级检索  
     


Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomized placebo‐controlled trial
Authors:Michel Komajda  Richard Isnard  Alain Cohen‐Solal  Marco Metra  Burkert Pieske  Piotr Ponikowski  Adriaan A. Voors  Fabienne Dominjon  Cécile Henon‐Goburdhun  Matthieu Pannaux  Michael B?hm
Affiliation:1. Department of Cardiology, University of Pierre and Marie Curie Paris VI, La Pitié‐Salpêtrière Hospital, Paris, France;2. UMR‐S 942, Department of Cardiology, Paris Diderot University, Sorbonne Paris Centre, Lariboisière Hospital, Paris, France;3. Department of Cardiology, University of Brescia, Brescia, Italy;4. Department of Cardiology, Charité University, Berlin, Germany;5. Department of Heart Diseases, Medical University and Centre for Heart Diseases, Military Hospital, Wroc?aw, Poland;6. Department of Cardiology, University of Groningen, Groningen, the Netherlands;7. Department of Cardiovascular Development, Institut de Recherches Internationales Servier (IRIS), Suresnes, France;8. Department of Methodology and Data Valorisation, Institut de Recherches Internationales Servier (IRIS), Suresnes, France;9. Department of Cardiology, Universit?tskliniken des Saarlandes, Klinikum für Innere Medizin III, Homburg/Saar, Germany
Abstract:
Keywords:Heart failure  Preserved ejection fraction  Ivabradine  Heart rate
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号